18 annual accounts with figures on one time axis, 25 filings since 2001
peak of €237,782 in 2025
€237,782▲ 59.0%
lowest -€56,860 in 2016
€59,137▲ 55.0%
peak of €583,045 in 2013
€457,752▲ 14.8%
€135,748▲ 273%
Board1 name since 2021
1 directorName hiddenVisible after signing in
Documentsfilings and deeds
08-07-202623 days before the deadline
2025micro format
Gross margin from €149,585 to €237,782Result from €38,165 to €59,137Equity from €398,615 to €457,752Debts from €36,364 to €135,748Cash from €89,671 to €142,287
Nine of the last ten came late. The 2019 accounts came in latest, 132 days after the end of the period.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 20,149 companies had the same profile as SYMEDIC has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
Small
20 years or older
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,149 companies, not a prediction for SYMEDIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0474031773
Hidden nameVisible after signing in reappointed as director
Gazette deed
Capital decrease to €18,600
The capital fell from €271,000 to €18,600 · General meeting of 15-12-2017 · Gazette deed
Capital increase of €253,000 to €271,600
The capital rose from €18,600 to €271,600, with 2,530 new shares · “Achat; Vente; Location; Mise en location; Construction; Démembrement de propriété usufruit - nue-propriété” (deed in French) · General meeting of 13-12-2013 · Gazette deed
Yes, SYMEDIC is an active enterprise in the KBO register.
What is the turnover of SYMEDIC?
The turnover in financial year 2025 is about €590,000. This figure is estimated from the gross margin of €237,782 and 2,458 comparable companies of the same size. It probably lies between €390,000 and €920,000. It is a rough estimate.Financials
Is SYMEDIC profitable?
In financial year 2025, SYMEDIC made a profit of €59,137.
Where can I find the annual accounts of SYMEDIC?
SYMEDIC filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SYMEDIC due?
SYMEDIC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline